Zoll Acquires CoAxia Assets In Bid To Revive NeuroFlo Stroke Catheter

CoAxia Inc. did not have the funds to continue after its de novo petition for the NeuroFlo catheter was rejected by FDA for acute ischemic stroke. But Zoll still sees opportunity for the device; now that it owns the technology, the firm plans to design a new pivotal trial to take before the agency.